Compensatory renal hypertrophy following nephrectomy: When and how?

Area of Science:

• Nephrology
• Renal Physiology
• Regenerative Medicine

Background:

• Compensatory renal hypertrophy (CRH) occurs after unilateral nephrectomy, increasing the remaining kidney's size and function.
• The precise mechanisms sensing renal mass reduction and initiating CRH remain incompletely understood.
• CRH is crucial for maintaining overall renal function in individuals donating kidneys or undergoing nephrectomy for conditions like cancer.

Purpose of the Study:

• To elucidate the underlying mechanisms of compensatory renal hypertrophy (CRH) following kidney removal.
• To investigate the proposed pathways involved in sensing renal mass reduction and initiating renal growth.
• To clarify the roles of specific growth factors and signaling pathways, including the hypoxia-inducible factor, in CRH.

Main Methods:

• Review of existing literature on renal adaptation post-nephrectomy.
• Analysis of proposed mechanisms: increased renal activity versus kidney-specific factor release.
• Examination of experimental evidence implicating growth factors and the mTORC pathway.

Main Results:

• Compensatory renal hypertrophy (CRH) is the primary driver of renal growth after unilateral nephrectomy.
• Two main hypotheses exist: increased workload stimulating hypertrophy or release of a specific factor.
• While growth factors and pathways like mTORC are implicated, their exact roles in CRH are not fully defined.

Conclusions:

• Understanding CRH mechanisms is vital for patients undergoing nephrectomy, such as kidney donors or cancer patients.
• Further research is needed to precisely define the signaling pathways and factors that control CRH.
• Hypoxia-inducible factor activation may play a significant role in driving CRH, particularly in the context of renal cancer.